Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.735 USD | +2.27% | +7.30% | -27.87% |
04-15 | TELA Bio, Inc. Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR | CI |
03-22 | Piper Sandler Adjusts Price Target on TELA Bio to $12 From $15, Maintains Overweight Rating | MT |
- Stock Market
- Equities
- TELA Stock
- News TELA Bio, Inc.
- Other languages